iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Up 570.8% in April

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 7,345 shares, a growth of 570.8% from the April 15th total of 1,095 shares. Currently, 2.0% of the shares of the stock are short sold. Based on an average trading volume of 3,855 shares, the short-interest ratio is currently 1.9 days.

iShares Health Innovation Active ETF Trading Down 0.6%

BMED traded down $0.17 on Thursday, hitting $27.81. 530 shares of the company’s stock were exchanged, compared to its average volume of 4,431. iShares Health Innovation Active ETF has a fifty-two week low of $23.23 and a fifty-two week high of $32.19. The stock has a market cap of $10.01 million, a price-to-earnings ratio of 24.91 and a beta of 0.75. The firm has a 50-day moving average price of $28.75 and a 200-day moving average price of $29.78.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. bought a new position in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned 3.63% of iShares Health Innovation Active ETF at the end of the most recent reporting period.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.